The size of the Global Cytokine Based Therapies and Inhibitors Market is estimated to grow at a healthy CAGR during the forecast period.
Cytokine Based Therapies and Inhibitors is a branch of science combining biology and engineering. It brings together several disciplines from both these fields such as genetic engineering, biotechnology, molecular engineering, computer engineering, and evolutionary biology. In Cytokine Based Therapies and Inhibitors, these disciplines are applied to build artificial biological systems to be used in engineering, research, and medical applications.
To achieve the intended biological system through DNA modification or sequencing, technology plays a major role. Computer-aided designs are needed to model the designs accurately and technologies that can read and write DNA are highly useful. By combining advances in biology with the modern technologies, organisms can be designed to produce several chemicals or enzymes or biofuels.
Increasing expenditure on research and development of biotechnology and pharmaceutical companies, increasing demand for genetically modified crops and major technological advancements in DNA studies are the major factors driving the market growth. Increasing demand for alternative fuels such as biofuels and growing popularity for protein therapeutics are also expected to propel the market growth.
However, ethical concerns regarding the biosafety and biosecurity and stringent regulations are hindering the growth of the market.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 - 2024 |
|
Segments Covered |
By Type, Therapeutic Application and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
GlaxoSmithKline LLC, AbbVie Inc., Eli Lilly and Company, Genentech, Inc., Immunochemistry Technologies LLC, Roche Diagnostics, Novartis, Merck Sharp & Dohme Corp., Johnson & Johnson and Amgen Inc. |
This research report on the Global Cytokine Based Therapies and Inhibitors Market segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2024.
Cytokine Based Therapies and Inhibitors Market Analysis – By Type:
Cytokine Based Therapies and Inhibitors Market Analysis – By Therapeutic Application:
Regional Analysis:
North America leads the Cytokine Based Therapies and Inhibitors market due to the presence of a large number of companies in Cytokine Based Therapies and Inhibitors and increasing investments from the government. The Asia Pacific is the fastest-growing market segment due to the growing awareness and increasing collaborations with western companies in China and also due to the well-established biotechnology industries in Japan.
List of most promising companies leading the Global Cytokine Based Therapies and Inhibitors Market profiled in this report are:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Interleukins
5.1.3 Tumor necrosis factor
5.1.4 Epidermal growth factor
5.1.5 Interferon
5.1.6 Chemokine
5.1.7 Y-o-Y Growth Analysis, By Type
5.1.8 Market Attractiveness Analysis, By Type
5.1.9 Market Share Analysis, By Type
5.2 Therapeutic Application
5.2.1 Introduction
5.2.2 Inflammatory and immune disorders
5.2.3 Cancer and malignancies
5.2.4 Infectious diseases
5.2.5 Others
5.2.6 Y-o-Y Growth Analysis, By Therapeutic Application
5.2.7 Market Attractiveness Analysis, By Therapeutic Application
5.2.8 Market Share Analysis, By Therapeutic Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Therapeutic Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Therapeutic Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Therapeutic Application
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 GlaxoSmithKline LLC
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 AbbVie Inc.
8.3 Eli Lilly and Company
8.4 Genentech, Inc
8.5 Immunochemistry Technologies LLC
8.6 Roche Diagnostics
8.7 Novartis
8.8 Merck Sharp & Dohme Corp
8.9 Johnson & Johnson
8.10 Amgen Inc
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
